Detalhe da pesquisa
1.
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
Allergy
; 79(2): 384-392, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37632144
2.
Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis.
Clin Exp Allergy
; 52(12): 1403-1413, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35475305
3.
Mepolizumab effectiveness and identification of super-responders in severe asthma.
Eur Respir J
; 55(5)2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32139455
4.
Effect of monoclonal antibody drug therapy on mucosal biomarkers in airway disease: A systematic review.
Clin Exp Allergy
; 50(11): 1212-1222, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32808380
5.
Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia.
Respirology
; 25(11): 1183-1192, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33020986
6.
Treatable traits can be identified in a severe asthma registry and predict future exacerbations.
Respirology
; 24(1): 37-47, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30230137
7.
Nasal mucosal brushing as a diagnostic method for allergic rhinitis.
Allergy Asthma Proc
; 40(3): 167-172, 2019 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31018891
8.
Local specific Immunoglobulin E among patients with nonallergic rhinitis: a systematic review.
Rhinology
; 57(1): 10-20, 2019 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30219822
9.
WITHDRAWN: Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis.
Cochrane Database Syst Rev
; 9: CD008263, 2018 09 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30184244
10.
Microgeographic factors and patterns of aeroallergen sensitisation.
Med J Aust
; 205(7): 310-5, 2016 Oct 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27681972
11.
Iatrogenic Cushing's syndrome with inhaled fluticasone.
Aust Prescr
; 42(4): 139-140, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31427846
12.
Comparison of Allergen Immunotherapy Alone and in Conjunction With Turbinate Surgery for Nasal Obstruction in Perennial Allergic Rhinitis Patients.
Ann Otol Rhinol Laryngol
; 133(6): 545-553, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38414187
13.
The future of allergic rhinitis management: A partnership between healthcare professionals and patients.
World Allergy Organ J
; 17(3): 100873, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38463017
14.
CCAD or eCRS: Defining Eosinophilic Subpopulations in Chronic Rhinosinusitis.
Am J Rhinol Allergy
; 37(4): 402-409, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36740860
15.
A Scoping Review of Artificial Intelligence Research in Rhinology.
Am J Rhinol Allergy
; 37(4): 438-448, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36895144
16.
Bacterial colonization differences between central compartment atopic disease and eosinophilic chronic rhinosinusitis.
Int Forum Allergy Rhinol
; 13(10): 1978-1981, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36905096
17.
The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy.
Explor Res Clin Soc Pharm
; 12: 100340, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37869069
18.
Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma.
J Allergy Clin Immunol Pract
; 11(3): 885-895.e13, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36572182
19.
Predictors of persistent disease in biologic treated type 2 diffuse/eosinophilic chronic rhinosinusitis undergoing surgery.
Int Forum Allergy Rhinol
; 2023 Oct 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37805956
20.
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity.
J Allergy Clin Immunol Pract
; 11(10): 3107-3115.e2, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37329954